메뉴 건너뛰기




Volumn 13, Issue 1, 2014, Pages 155-173

Novel approaches in polyepitope T-cell vaccine development against HIV-1

Author keywords

CD4+ T cells; CD8+ T cells; HIV 1; MHC class I molecules; MHC class II molecules; mucosal immunity; polyepitope T cell immunogen; rational design; vaccine; vaccine delivery

Indexed keywords

AUTOANTIBODY; CD4 ANTIGEN; CD8 ANTIGEN; DNA VACCINE; EPITOPE; HLA A2 ANTIGEN; HLA A3 ANTIGEN; HLA B7 ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NEUTRALIZING ANTIBODY;

EID: 84893127005     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/14760584.2014.861748     Document Type: Review
Times cited : (24)

References (191)
  • 1
    • 0035751961 scopus 로고    scopus 로고
    • Strategies for designing and optimizing new generation vaccines
    • Berzofsky JA, Ahlers JD, Belyakov IM. Strategies for designing and optimizing new generation vaccines. Nat. Rev. Immunol. 1(3), 209-219 (2001).
    • (2001) Nat. Rev. Immunol , vol.1 , Issue.3 , pp. 209-219
    • Berzofsky, J.A.1    Ahlers, J.D.2    Belyakov, I.M.3
  • 3
    • 84856185924 scopus 로고    scopus 로고
    • Mucosal immunity and HIV-1 infection: Applications for mucosal AIDS vaccine development
    • Belyakov IM, Ahlers JD. Mucosal immunity and HIV-1 infection: applications for mucosal AIDS vaccine development. Curr. Topics Microbiol. Immunol. 354, 157-179 (2012).
    • (2012) Curr. Topics Microbiol. Immunol , vol.354 , pp. 157-179
    • Belyakov, I.M.1    Ahlers, J.D.2
  • 4
    • 84875520974 scopus 로고    scopus 로고
    • A molecular basis for the control of preimmune escape variants by HIV-specific CD8+ T cells
    • Ladell K, Hashimoto M, Iglesias MC et al. A molecular basis for the control of preimmune escape variants by HIV-specific CD8+ T cells. Immunity 38(3), 425-436 (2013).
    • (2013) Immunity , vol.38 , Issue.3 , pp. 425-436
    • Ladell, K.1    Hashimoto, M.2    Iglesias, M.C.3
  • 5
    • 77953118149 scopus 로고    scopus 로고
    • Innate and adaptive immune correlates of vaccine and adjuvant-induced control of mucosal transmission of SIV in macaques
    • Sui YJ, Zhu Q, Gagnon S et al. Innate and adaptive immune correlates of vaccine and adjuvant-induced control of mucosal transmission of SIV in macaques. Proc. Natl Acad. Sci. USA 107(21), 9843-9848 (2010).
    • (2010) Proc. Natl Acad. Sci. USA , vol.107 , Issue.21 , pp. 9843-9848
    • Sui, Y.J.1    Zhu, Q.2    Gagnon, S.3
  • 6
    • 77957342368 scopus 로고    scopus 로고
    • New Paradigms for Generating Effective CD8(+) T Cell Responses Against HIV-1/AIDS
    • Ahlers JD, Belyakov IM. New Paradigms for Generating Effective CD8(+) T Cell Responses Against HIV-1/AIDS. Discov. Med. 49, 528-537 (2010).
    • (2010) Discov. Med , vol.49 , pp. 528-537
    • Ahlers, J.D.1    Belyakov, I.M.2
  • 7
    • 0024425906 scopus 로고
    • Synergism between hiv-gp120 and gp120-specific antibody in blocking human T-cell activation
    • Mittler RS, Hoffmann MK. Synergism between hiv-gp120 and gp120-specific antibody in blocking human T-cell activation. Science 245(4924), 1380-1382 (1989).
    • (1989) Science , vol.245 , Issue.4924 , pp. 1380-1382
    • Mittler, R.S.1    Hoffmann, M.K.2
  • 8
    • 84870686308 scopus 로고    scopus 로고
    • New generation humanized mice for virus research: Comparative aspects and future prospects
    • Akkina R. New generation humanized mice for virus research: comparative aspects and future prospects. Virology 435(1), 14-28 (2013).
    • (2013) Virology , vol.435 , Issue.1 , pp. 14-28
    • Akkina, R.1
  • 9
    • 13944254982 scopus 로고    scopus 로고
    • Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection
    • Flynn MN, Forthal DN, Harro CD et al. Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection. J. Infect. Dis. 191(5), 654-665 (2005).
    • (2005) J. Infect. Dis , vol.191 , Issue.5 , pp. 654-665
    • Flynn, M.N.1    Forthal, D.N.2    Harro, C.D.3
  • 10
    • 56649105122 scopus 로고    scopus 로고
    • Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): A double-blind, randomised, placebo-controlled, test-of-concept trial
    • Buchbinder SP, Mehrotra DV, Duerr A et al. Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial. Lancet 372(9653), 1881-1893 (2008).
    • (2008) Lancet , vol.372 , Issue.9653 , pp. 1881-1893
    • Buchbinder, S.P.1    Mehrotra, D.V.2    Duerr, A.3
  • 11
    • 38749096240 scopus 로고    scopus 로고
    • The failed HIV Merck vaccine study: A step back or a launching point for future vaccine development?
    • Sekaly RP. The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development? J. Exp. Med. 205(1), 7-12 (2008).
    • (2008) J. Exp. Med , vol.205 , Issue.1 , pp. 7-12
    • Sekaly, R.P.1
  • 12
    • 84859919465 scopus 로고    scopus 로고
    • Lessons learned from HIV-1 vaccine trials: New priorities and directions
    • Mcmichael AJ, Haynes BF. Lessons learned from HIV-1 vaccine trials: new priorities and directions. Nat. Immunol. 13(5), 423-427 (2012).
    • (2012) Nat. Immunol , vol.13 , Issue.5 , pp. 423-427
    • McMichael, A.J.1    Haynes, B.F.2
  • 13
    • 84873051328 scopus 로고    scopus 로고
    • Antigenicity and immunogenicity of RV144 vaccine AIDSVAX clade e envelope immunogen is enhanced by a gp120 N-terminal deletion
    • Alam SM, Liao HX, Tomaras GD et al. Antigenicity and immunogenicity of RV144 vaccine AIDSVAX clade E envelope immunogen is enhanced by a gp120 N-terminal deletion. J. Virol. 87(3), 1554-1568 (2013).
    • (2013) J. Virol , vol.87 , Issue.3 , pp. 1554-1568
    • Alam, S.M.1    Liao, H.X.2    Tomaras, G.D.3
  • 14
    • 84859393693 scopus 로고    scopus 로고
    • Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial
    • Haynes BF, Gilbert PB, Mcelrath MJ et al. Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial. N. Engl. J. Med. 366(14), 1275-1286 (2012).
    • (2012) N. Engl. J. Med , vol.366 , Issue.14 , pp. 1275-1286
    • Haynes, B.F.1    Gilbert, P.B.2    McElrath, M.J.3
  • 15
    • 84880714310 scopus 로고    scopus 로고
    • A brief history of the global effort to develop a preventive HIV vaccine
    • Esparza J. A brief history of the global effort to develop a preventive HIV vaccine. Vaccine 31(35), 3502-3518 (2013).
    • (2013) Vaccine , vol.31 , Issue.35 , pp. 3502-3518
    • Esparza, J.1
  • 16
    • 79955000186 scopus 로고    scopus 로고
    • HIV vaccine efficacy trial: Glimmers of hope and the potential role of antibody-dependent cellular cytotoxicity
    • Wren L, Kent SJ. HIV vaccine efficacy trial: glimmers of hope and the potential role of antibody-dependent cellular cytotoxicity. Hum. Vaccin. 7(4), 467-474 (2011).
    • (2011) Hum. Vaccin , vol.7 , Issue.4 , pp. 467-474
    • Wren, L.1    Kent, S.J.2
  • 17
    • 4644289983 scopus 로고    scopus 로고
    • Primary HIV-1 infection is associated with preferential depletion of CD4(+) T lymphocytes from effector sites in the gastrointestinal tract
    • Mehandru S, Poles MA, Tenner-Racz K et al. Primary HIV-1 infection is associated with preferential depletion of CD4(+) T lymphocytes from effector sites in the gastrointestinal tract. J. Exp. Med. 200(6), 761-770 (2004).
    • (2004) J. Exp. Med , vol.200 , Issue.6 , pp. 761-770
    • Mehandru, S.1    Poles, M.A.2    Tenner-Racz, K.3
  • 18
    • 0142092389 scopus 로고    scopus 로고
    • Severe CD4(+) T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy
    • Guadalupe M, Reay E, Sankaran S et al. Severe CD4(+) T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy. J. Virol. 77(21), 11708-11717 (2003).
    • (2003) J. Virol , vol.77 , Issue.21 , pp. 11708-11717
    • Guadalupe, M.1    Reay, E.2    Sankaran, S.3
  • 19
    • 73349104433 scopus 로고    scopus 로고
    • What Role Does the Route of Immunization Play in the Generation of Protective Immunity against Mucosal Pathogens?
    • Belyakov IM, Ahlers JD. What Role Does the Route of Immunization Play in the Generation of Protective Immunity against Mucosal Pathogens? J. Immunol. 183(11), 6883-6892 (2009).
    • (2009) J. Immunol , vol.183 , Issue.11 , pp. 6883-6892
    • Belyakov, I.M.1    Ahlers, J.D.2
  • 20
    • 0035661880 scopus 로고    scopus 로고
    • Mucosal AIDS vaccine reduces disease and viral load in gut reservoir and blood after mucosal infection of macaques
    • Belyakov IM, Hel Z, Kelsall B et al. Mucosal AIDS vaccine reduces disease and viral load in gut reservoir and blood after mucosal infection of macaques. Nat. Med. 7(12), 1320-1326 (2001).
    • (2001) Nat. Med , vol.7 , Issue.12 , pp. 1320-1326
    • Belyakov, I.M.1    Hel, Z.2    Kelsall, B.3
  • 21
    • 34249786561 scopus 로고    scopus 로고
    • A novel functional CTL avidity/activity compartmentalization to the site of mucosal immunization contributes to protection of macaques against simian/ human immunodeficiency viral depletion of mucosal CD4(+) T cells
    • Belyakov IM, Isakov D, Zhu Q, Dzutsev A, Berzofsky JA. A novel functional CTL avidity/activity compartmentalization to the site of mucosal immunization contributes to protection of macaques against simian/ human immunodeficiency viral depletion of mucosal CD4(+) T cells. J. Immunol. 178(11), 7211-7221 (2007).
    • (2007) J. Immunol , vol.178 , Issue.11 , pp. 7211-7221
    • Belyakov, I.M.1    Isakov, D.2    Zhu, Q.3    Dzutsev, A.4    Berzofsky, J.A.5
  • 22
    • 77950627264 scopus 로고    scopus 로고
    • Rational design based synthetic polyepitope DNA vaccine for eliciting HIV-specific CD8+T cell responses
    • Bazhan SI, Karpenko LI, Ilyicheva TN et al. Rational design based synthetic polyepitope DNA vaccine for eliciting HIV-specific CD8+T cell responses. Mol. Immunol. 47(7-8), 1507-1515 (2010).
    • (2010) Mol. Immunol , vol.47 , Issue.7-8 , pp. 1507-1515
    • Bazhan, S.I.1    Karpenko, L.I.2    Ilyicheva, T.N.3
  • 23
    • 84858343126 scopus 로고    scopus 로고
    • Polyepitope protein incorporated the HIV-1 mimotope recognized by monoclonal antibody 2G12
    • Karpenko LI, Scherbakova NS, Chikaev AN et al. Polyepitope protein incorporated the HIV-1 mimotope recognized by monoclonal antibody 2G12. Mol. Immunol. 50(4), 193-199 (2012).
    • (2012) Mol. Immunol , vol.50 , Issue.4 , pp. 193-199
    • Karpenko, L.I.1    Scherbakova, N.S.2    Chikaev, A.N.3
  • 24
    • 0032007497 scopus 로고    scopus 로고
    • DNA multi-CTL epitope vaccines for HIV and Plasmodium falciparum: Immunogenicity in mice
    • Hanke T, Schneider J, Gilbert SC, Hill AVS, Mcmichael A. DNA multi-CTL epitope vaccines for HIV and Plasmodium falciparum: immunogenicity in mice. Vaccine 16(4), 426-435 (1998).
    • (1998) Vaccine , vol.16 , Issue.4 , pp. 426-435
    • Hanke, T.1    Schneider, J.2    Gilbert, S.C.3    Avs, H.4    McMichael, A.5
  • 25
    • 8944252799 scopus 로고    scopus 로고
    • Recombinant polyepitope vaccines for the delivery of multiple CD8 cytotoxic T cell epitopes
    • Thomson SA, Elliott SL, Sherritt MA et al. Recombinant polyepitope vaccines for the delivery of multiple CD8 cytotoxic T cell epitopes. J. Immunol. 157(2), 822-826 (1996).
    • (1996) J. Immunol , vol.157 , Issue.2 , pp. 822-826
    • Thomson, S.A.1    Elliott, S.L.2    Sherritt, M.A.3
  • 26
    • 11144357556 scopus 로고    scopus 로고
    • Designing and engineering of DNA-vaccine construction encoding multiple CTL-epitopes of major HIV-1 antigens
    • Bazhan SI, Belavin PA, Seregin SV et al. Designing and engineering of DNA-vaccine construction encoding multiple CTL-epitopes of major HIV-1 antigens. Vaccine 22(13-14), 1672-1682 (2004).
    • (2004) Vaccine , vol.22 , Issue.13-14 , pp. 1672-1682
    • Bazhan, S.I.1    Belavin, P.A.2    Seregin, S.V.3
  • 27
    • 33846111016 scopus 로고    scopus 로고
    • Polyvalent vaccines for optimal coverage of potential T-cell epitopes in global HIV-1 variants
    • Fischer W, Perkins S, Theiler J et al. Polyvalent vaccines for optimal coverage of potential T-cell epitopes in global HIV-1 variants. Nat. Med. 13(1), 100-106 (2007).
    • (2007) Nat. Med , vol.13 , Issue.1 , pp. 100-106
    • Fischer, W.1    Perkins, S.2    Theiler, J.3
  • 28
    • 19944427052 scopus 로고    scopus 로고
    • Antigenicity and immunogenicity of a synthetic human immunodeficiency virus type i group m consensus envelope glycoprotein
    • Gao F, Weaver EA, Lu ZJ et al. Antigenicity and immunogenicity of a synthetic human immunodeficiency virus type I group m consensus envelope glycoprotein. J. Virol. 79(2), 1154-1163 (2005).
    • (2005) J. Virol , vol.79 , Issue.2 , pp. 1154-1163
    • Gao, F.1    Weaver, E.A.2    Lu, Z.J.3
  • 29
    • 33745771090 scopus 로고    scopus 로고
    • Cross-subtype T-cell immune responses induced by a human immunodeficiency virus type 1 group M consensus env immunogen
    • Weaver EA, Lu ZJ, Camacho ZT et al. Cross-subtype T-cell immune responses induced by a human immunodeficiency virus type 1 group M consensus env immunogen. J. Virol. 80(14), 6745-6756 (2006).
    • (2006) J. Virol , vol.80 , Issue.14 , pp. 6745-6756
    • Weaver, E.A.1    Lu, Z.J.2    Camacho, Z.T.3
  • 30
    • 0032539614 scopus 로고    scopus 로고
    • Mucosal immunization with HIV-1 peptide vaccine induces mucosal and systemic cytotoxic T lymphocytes and protective immunity in mice against intrarectal recombinant HIV-vaccinia challenge
    • Belyakov IM, Derby MA, Ahlers JD et al. Mucosal immunization with HIV-1 peptide vaccine induces mucosal and systemic cytotoxic T lymphocytes and protective immunity in mice against intrarectal recombinant HIV-vaccinia challenge. Proc. Natl Acad. Sci. USA 95(4), 1709-1714 (1998).
    • (1998) Proc. Natl Acad. Sci. USA , vol.95 , Issue.4 , pp. 1709-1714
    • Belyakov, I.M.1    Derby, M.A.2    Ahlers, J.D.3
  • 31
    • 0032869689 scopus 로고    scopus 로고
    • Approaches to improve engineered vaccines for human immunodeficiency virus and other viruses that cause chronic infections
    • Berzofsky JA, Ahlers JD, Derby MA, Pendleton CD, Arichi T, Belyakov IM. Approaches to improve engineered vaccines for human immunodeficiency virus and other viruses that cause chronic infections. Immunol. Rev. 170, 151-172 (1999).
    • (1999) Immunol. Rev , vol.170 , pp. 151-172
    • Berzofsky, J.A.1    Ahlers, J.D.2    Derby, M.A.3    Pendleton, C.D.4    Arichi, T.5    Belyakov, I.M.6
  • 32
    • 34247323484 scopus 로고    scopus 로고
    • Combined virus-like particle-based polyepitope DNA/protein HIV-1 vaccine -Design, immunogenicity and toxicity studies
    • Karpenko LI, Ilyichev AA, Eroshkin AM et al. Combined virus-like particle-based polyepitope DNA/protein HIV-1 vaccine -Design, immunogenicity and toxicity studies. Vaccine 25(21), 4312-4323 (2007).
    • (2007) Vaccine , vol.25 , Issue.21 , pp. 4312-4323
    • Karpenko, L.I.1    Ilyichev, A.A.2    Eroshkin, A.M.3
  • 33
    • 54949106244 scopus 로고    scopus 로고
    • Broad immunogenicity of a multigene, multiclade HIV-1 DNA vaccine boosted with heterologous HIV-1 recombinant modified vaccinia virus ankara
    • Sandstrom E, Nilsson C, Hejdeman B et al. Broad immunogenicity of a multigene, multiclade HIV-1 DNA vaccine boosted with heterologous HIV-1 recombinant modified vaccinia virus ankara. J. Infect. Dis. 198(10), 1482-1490 (2008).
    • (2008) J. Infect. Dis , vol.198 , Issue.10 , pp. 1482-1490
    • Sandstrom, E.1    Nilsson, C.2    Hejdeman, B.3
  • 34
    • 77954097759 scopus 로고    scopus 로고
    • Long peptides induce polyfunctional T cells against conserved regions of HIV-1 with superior breadth to single-gene vaccines in macaques
    • Rosario M, Bridgeman A, Quakkelaar ED et al. Long peptides induce polyfunctional T cells against conserved regions of HIV-1 with superior breadth to single-gene vaccines in macaques. Eur. J. Immunol. 40(7), 1973-1984 (2010).
    • (2010) Eur. J. Immunol , vol.40 , Issue.7 , pp. 1973-1984
    • Rosario, M.1    Bridgeman, A.2    Quakkelaar, E.D.3
  • 35
    • 84861401590 scopus 로고    scopus 로고
    • Superior Induction of T Cell Responses to Conserved HIV-1 Regions by Electroporated Alphavirus Replicon DNA Compared to That with Conventional Plasmid DNA Vaccine
    • Knudsen ML, Mbewe-Mvula A, Rosario M et al. Superior Induction of T Cell Responses to Conserved HIV-1 Regions by Electroporated Alphavirus Replicon DNA Compared to That with Conventional Plasmid DNA Vaccine. Journal of Virology 86(8), 4082-4090 (2012).
    • (2012) Journal of Virology , vol.86 , Issue.8 , pp. 4082-4090
    • Knudsen, M.L.1    Mbewe-Mvula, A.2    Rosario, M.3
  • 36
    • 84857223044 scopus 로고    scopus 로고
    • Attenuated Salmonella enteritidis E23 as a vehicle for the rectal delivery of DNA vaccine coding for HIV-1 polyepitope CTL immunogen
    • Karpenko LI, Danilenko AV, Bazhan SI et al. Attenuated Salmonella enteritidis E23 as a vehicle for the rectal delivery of DNA vaccine coding for HIV-1 polyepitope CTL immunogen. Microb. Biotechnol. 5(2), 241-250 (2012).
    • (2012) Microb. Biotechnol , vol.5 , Issue.2 , pp. 241-250
    • Karpenko, L.I.1    Danilenko, A.V.2    Bazhan, S.I.3
  • 37
    • 78650663587 scopus 로고    scopus 로고
    • Preexisting Vaccinia Virus Immunity Decreases SIV-Specific Cellular Immunity but Does Not Diminish Humoral Immunity and Efficacy of a DNA/ MVA Vaccine
    • Kannanganat S, Nigam P, Velu V et al. Preexisting Vaccinia Virus Immunity Decreases SIV-Specific Cellular Immunity but Does Not Diminish Humoral Immunity and Efficacy of a DNA/ MVA Vaccine. J. Immunol. 185(12), 7262-7273 (2010).
    • (2010) J. Immunol , vol.185 , Issue.12 , pp. 7262-7273
    • Kannanganat, S.1    Nigam, P.2    Velu, V.3
  • 38
    • 0033826855 scopus 로고    scopus 로고
    • Design and construction of an experimental HIV-1 vaccine for a year-2000 clinical trial in Kenya
    • Hanke T, Mcmichael AJ. Design and construction of an experimental HIV-1 vaccine for a year-2000 clinical trial in Kenya. Nat. Med. 6(9), 951-955 (2000).
    • (2000) Nat. Med , vol.6 , Issue.9 , pp. 951-955
    • Hanke, T.1    McMichael, A.J.2
  • 39
    • 0033524838 scopus 로고    scopus 로고
    • Control of viremia in simian immunodeficiency virus infection by CD8(+) lymphocytes
    • Schmitz JE, Kuroda MJ, Santra S et al. Control of viremia in simian immunodeficiency virus infection by CD8(+) lymphocytes. Science 283(5403), 857-860 (1999).
    • (1999) Science , vol.283 , Issue.5403 , pp. 857-860
    • Schmitz, J.E.1    Kuroda, M.J.2    Santra, S.3
  • 40
    • 0030997137 scopus 로고    scopus 로고
    • Suppression of human immunodeficiency virus type 1 replication by CD8(+) cells: Evidence for HLA class I-restricted triggering of cytolytic and noncytolytic mechanisms
    • Yang OO, Kalams SA, Trocha A et al. Suppression of human immunodeficiency virus type 1 replication by CD8(+) cells: Evidence for HLA class I-restricted triggering of cytolytic and noncytolytic mechanisms. J. Virol. 71(4), 3120-3128 (1997).
    • (1997) J. Virol , vol.71 , Issue.4 , pp. 3120-3128
    • Yang, O.O.1    Kalams, S.A.2    Trocha, A.3
  • 41
    • 77649193824 scopus 로고    scopus 로고
    • In Vivo CD8+T-Cell Suppression of SIV Viremia Is Not Mediated by CTL Clearance of Productively Infected Cells
    • Wong JK, Strain MC, Porrata R et al. In Vivo CD8+T-Cell Suppression of SIV Viremia Is Not Mediated by CTL Clearance of Productively Infected Cells. PLoS Pathog. 6(1) (2010).
    • (2010) PLoS Pathog , vol.6 , Issue.1
    • Wong, J.K.1    Strain, M.C.2    Porrata, R.3
  • 42
    • 77649217418 scopus 로고    scopus 로고
    • CD8 +Lymphocytes Control Viral Replication in SIVmac239-Infected Rhesus Macaques without Decreasing the Lifespan of Productively Infected Cells
    • Klatt NR, Shudo E, Ortiz AM et al. CD8 +Lymphocytes Control Viral Replication in SIVmac239-Infected Rhesus Macaques without Decreasing the Lifespan of Productively Infected Cells. PLoS Pathog. 6(1) (2010).
    • (2010) PLoS Pathog , vol.6 , Issue.1
    • Klatt, N.R.1    Shudo, E.2    Ortiz, A.M.3
  • 43
    • 0032567942 scopus 로고    scopus 로고
    • Beta-chemokines are released from HIV-1-specific cytolytic T-cell granules complexed to proteoglycans
    • Wagner L, Yang OO, Garcia-Zepeda EA et al. beta-chemokines are released from HIV-1-specific cytolytic T-cell granules complexed to proteoglycans. Nature 391(6670), 908-911 (1998).
    • (1998) Nature , vol.391 , Issue.6670 , pp. 908-911
    • Wagner, L.1    Yang, O.O.2    Garcia-Zepeda, E.A.3
  • 44
    • 0032510455 scopus 로고    scopus 로고
    • Antigen-specific release of beta-chemokines by anti-HIV-1 cytotoxic T lymphocytes
    • Price DA, Sewell AK, Dong T et al. Antigen-specific release of beta-chemokines by anti-HIV-1 cytotoxic T lymphocytes. Curr. Biol. 8(6), 355-358 (1998).
    • (1998) Curr. Biol , vol.8 , Issue.6 , pp. 355-358
    • Price, D.A.1    Sewell, A.K.2    Dong, T.3
  • 45
    • 0034600786 scopus 로고    scopus 로고
    • HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function
    • Appay V, Nixon DF, Donahoe SM et al. HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function. J. Exp. Med. 192(1), 63-75 (2000).
    • (2000) J. Exp. Med , vol.192 , Issue.1 , pp. 63-75
    • Appay, V.1    Nixon, D.F.2    Donahoe, S.M.3
  • 46
    • 0036134852 scopus 로고    scopus 로고
    • Vaccine protection against functional CTL abnormalities in simian human immunodeficiency virus-infected rhesus monkeys
    • Mckay PF, Schmitz JE, Barouch DH et al. Vaccine protection against functional CTL abnormalities in simian human immunodeficiency virus-infected rhesus monkeys. J. Immunol. 168(1), 332-337 (2002).
    • (2002) J. Immunol , vol.168 , Issue.1 , pp. 332-337
    • McKay, P.F.1    Schmitz, J.E.2    Barouch, D.H.3
  • 47
    • 33646003876 scopus 로고    scopus 로고
    • Preservation of functional virus-specific memory CD8(+) T lymphocytes in vaccinated, simian human immunodeficiency virus-infected rhesus monkeys
    • Acierno PM, Schmitz JE, Gorgone DA et al. Preservation of functional virus-specific memory CD8(+) T lymphocytes in vaccinated, simian human immunodeficiency virus-infected rhesus monkeys. J. Immunol. 176(9), 5338-5345 (2006).
    • (2006) J. Immunol , vol.176 , Issue.9 , pp. 5338-5345
    • Acierno, P.M.1    Schmitz, J.E.2    Gorgone, D.A.3
  • 48
    • 7144227284 scopus 로고    scopus 로고
    • Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA
    • Ogg GS, Jin X, Bonhoeffer S et al. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science 279(5359), 2103-2106 (1998).
    • (1998) Science , vol.279 , Issue.5359 , pp. 2103-2106
    • Ogg, G.S.1    Jin, X.2    Bonhoeffer, S.3
  • 49
    • 0041751271 scopus 로고    scopus 로고
    • Molecular mechanisms and biological significance of CTL avidity
    • Snyder JT, Alexander-Miller MA, Berzofsky JA, Belyakov IM. Molecular mechanisms and biological significance of CTL avidity. Curr. HIV Res. 1(3), 287-294 (2003).
    • (2003) Curr. HIV Res , vol.1 , Issue.3 , pp. 287-294
    • Snyder, J.T.1    Ma, A.2    Berzofsky, J.A.3    Belyakov, I.M.4
  • 50
    • 33645748846 scopus 로고    scopus 로고
    • Impact of vaccine-induced mucosal high-avidity CD8(+)CTLs in delay of AIDS viral dissemination from mucosa
    • Belyakov IM, Kuznetsov VA, Kelsall B et al. Impact of vaccine-induced mucosal high-avidity CD8(+)CTLs in delay of AIDS viral dissemination from mucosa. Blood 107(8), 3258-3264 (2006).
    • (2006) Blood , vol.107 , Issue.8 , pp. 3258-3264
    • Belyakov, I.M.1    Kuznetsov, V.A.2    Kelsall, B.3
  • 51
    • 0035937587 scopus 로고    scopus 로고
    • Preferential localization of effector memory cells in nonlymphoid tissue
    • Masopust D, Vezys V, Marzo AL, Lefrancois L. Preferential localization of effector memory cells in nonlymphoid tissue. Science 291(5512), 2413-2417 (2001).
    • (2001) Science , vol.291 , Issue.5512 , pp. 2413-2417
    • Masopust, D.1    Vezys, V.2    Marzo, A.L.3    Lefrancois, L.4
  • 52
    • 33646686040 scopus 로고    scopus 로고
    • HIV nonprogressors preferentially maintain highly functional HIV-specific CD8(+) T cells
    • Betts MR, Nason MC, West SM et al. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8(+) T cells. Blood 107(12), 4781-4789 (2006).
    • (2006) Blood , vol.107 , Issue.12 , pp. 4781-4789
    • Betts, M.R.1    Nason, M.C.2    West, S.M.3
  • 53
    • 0035815437 scopus 로고    scopus 로고
    • Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine
    • Amara RR, Villinger F, Altman JD et al. Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine. Science 292(5514), 69-74 (2001).
    • (2001) Science , vol.292 , Issue.5514 , pp. 69-74
    • Amara, R.R.1    Villinger, F.2    Altman, J.D.3
  • 54
    • 12944284593 scopus 로고    scopus 로고
    • Augmentation of immune responses to HIV-1 and simian immunodeficiency virus DNA vaccines by IL-2/Ig plasmid administration in rhesus monkeys
    • Barouch DH, Craiu A, Kuroda MJ et al. Augmentation of immune responses to HIV-1 and simian immunodeficiency virus DNA vaccines by IL-2/Ig plasmid administration in rhesus monkeys. Proc. Natl Acad. Sci. USA 97(8), 4192-4197 (2000).
    • (2000) Proc. Natl Acad. Sci. USA , vol.97 , Issue.8 , pp. 4192-4197
    • Barouch, D.H.1    Craiu, A.2    Kuroda, M.J.3
  • 55
    • 0037122719 scopus 로고    scopus 로고
    • Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity
    • Shiver JW, Fu TM, Chen L et al. Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity. Nature 415(6869), 331-335 (2002).
    • (2002) Nature , vol.415 , Issue.6869 , pp. 331-335
    • Shiver, J.W.1    Fu, T.M.2    Chen, L.3
  • 56
    • 0026764311 scopus 로고
    • Proteolysis, proteasomes and antigen presentation
    • Goldberg AL, Rock KL. Proteolysis, proteasomes and antigen presentation. Nature 357(6377), 375-379 (1992).
    • (1992) Nature , vol.357 , Issue.6377 , pp. 375-379
    • Goldberg, A.L.1    Rock, K.L.2
  • 58
    • 0029920469 scopus 로고    scopus 로고
    • Antigen processing and presentation by the class i major histocompatibility complex
    • York IA, Rock KL. Antigen processing and presentation by the class I major histocompatibility complex. Ann. Rev. Immunol. 14, 369-396 (1996).
    • (1996) Ann. Rev. Immunol , vol.14 , pp. 369-396
    • York, I.A.1    Rock, K.L.2
  • 59
    • 0034657243 scopus 로고    scopus 로고
    • Incomplete CD8 (+) T lymphocyte differentiation as a mechanism for subdominant cytotoxic T lymphocyte responses to a viral antigen
    • Spencer JV, Braciale TJ. Incomplete CD8 (+) T lymphocyte differentiation as a mechanism for subdominant cytotoxic T lymphocyte responses to a viral antigen. J. Exp. Med. 191(10), 1687-1698 (2000).
    • (2000) J. Exp. Med , vol.191 , Issue.10 , pp. 1687-1698
    • Spencer, J.V.1    Braciale, T.J.2
  • 60
    • 0028117816 scopus 로고
    • An hla-based approach to the design of a ctl-inducing vaccine against plasmodium-falciparum
    • Lalvani A, Aidoo M, Allsopp CEM, Plebanski M, Whittle HC, Hill AVS. An hla-based approach to the design of a ctl-inducing vaccine against plasmodium-falciparum. Res. Immunol. 145(6), 461-468 (1994).
    • (1994) Res. Immunol , vol.145 , Issue.6 , pp. 461-468
    • Lalvani, A.1    Aidoo, M.2    Cem, A.3    Plebanski, M.4    Whittle, H.C.5    Avs, H.6
  • 61
    • 0029897044 scopus 로고    scopus 로고
    • Practical, biochemical and evolutionary implications of the discovery of HLA class i supermotifs
    • Sidney J, Grey HM, Kubo RT, Sette A. Practical, biochemical and evolutionary implications of the discovery of HLA class I supermotifs. Immunol. Today 17(6), 261-266 (1996).
    • (1996) Immunol. Today , vol.17 , Issue.6 , pp. 261-266
    • Sidney, J.1    Grey, H.M.2    Kubo, R.T.3    Sette, A.4
  • 62
    • 0033046472 scopus 로고    scopus 로고
    • Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses
    • Yewdell JTW, Bennink Jr. Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses. Ann. Rev. Immunol. 17, 51-88 (1999).
    • (1999) Ann. Rev. Immunol , vol.17 , pp. 51-88
    • Jtw, Y.1    Bennink, J.R.2
  • 63
    • 0002866386 scopus 로고    scopus 로고
    • Dissecting the multifactorial causes of immunodominance in class I-restricted T cell responses to viruses
    • Chen WS, Anton LC, Bennink JR, Yewdell JW. Dissecting the multifactorial causes of immunodominance in class I-restricted T cell responses to viruses. Immunity 12(1), 83-93 (2000).
    • (2000) Immunity , vol.12 , Issue.1 , pp. 83-93
    • Chen, W.S.1    Anton, L.C.2    Bennink, J.R.3    Yewdell, J.W.4
  • 64
    • 0026599764 scopus 로고
    • Flanking sequences influence the presentation of an endogenously synthesized peptide to cytotoxic lymphocytes-T
    • Eisenlohr LC, Yewdell JW, Bennink Jr. Flanking sequences influence the presentation of an endogenously synthesized peptide to cytotoxic lymphocytes-T. J. Exp. Med. 175(2), 481-487 (1992).
    • (1992) J. Exp. Med , vol.175 , Issue.2 , pp. 481-487
    • Eisenlohr, L.C.1    Yewdell, J.W.2    Bennink, J.R.3
  • 66
    • 0031569179 scopus 로고    scopus 로고
    • MHC class I-associated peptides produced from endogenous gene products with vastly different efficiencies
    • Anton LC, Yewdell JW, Bennink Jr. MHC class I-associated peptides produced from endogenous gene products with vastly different efficiencies. J. Immunol. 158(6), 2535-2542 (1997).
    • (1997) J. Immunol , vol.158 , Issue.6 , pp. 2535-2542
    • Anton, L.C.1    Yewdell, J.W.2    Bennink, J.R.3
  • 67
    • 0030849769 scopus 로고    scopus 로고
    • Localization, quantitation, and in situ detection of specific peptide MHC class i complexes using a monoclonal antibody
    • Porgador A, Yewdell JW, Deng YP, Bennink JR, Germain RN. Localization, quantitation, and in situ detection of specific peptide MHC class I complexes using a monoclonal antibody. Immunity 6(6), 715-726 (1997).
    • (1997) Immunity , vol.6 , Issue.6 , pp. 715-726
    • Porgador, A.1    Yewdell, J.W.2    Deng, Y.P.3    Bennink, J.R.4    Germain, R.N.5
  • 68
    • 7144223429 scopus 로고    scopus 로고
    • Proteasomes can either generate or destroy MHC class i epitopes: Evidence for nonproteasomal epitope generation in the cytosol
    • Luckey CJ, King GM, Marto JA et al. Proteasomes can either generate or destroy MHC class I epitopes: Evidence for nonproteasomal epitope generation in the cytosol. J. Immunol. 161(1), 112-121 (1998).
    • (1998) J. Immunol , vol.161 , Issue.1 , pp. 112-121
    • Luckey, C.J.1    King, G.M.2    Marto, J.A.3
  • 69
    • 2642607007 scopus 로고    scopus 로고
    • An endoplasmic reticulum-targeting signal sequence enhances the immunogenicity of an immunorecessive simian virus 40 large T antigen cytotoxic T-lymphocyte epitope
    • Fu TM, Mylin LM, Schell TD et al. An endoplasmic reticulum-targeting signal sequence enhances the immunogenicity of an immunorecessive simian virus 40 large T antigen cytotoxic T-lymphocyte epitope. J. Virol. 72(2), 1469-1481 (1998).
    • (1998) J. Virol , vol.72 , Issue.2 , pp. 1469-1481
    • Fu, T.M.1    Mylin, L.M.2    Schell, T.D.3
  • 70
    • 15644375065 scopus 로고    scopus 로고
    • Promiscuous liberation of MHC-class I-binding peptides from the C termini of membrane and soluble proteins in the secretory pathway
    • Snyder HL, Bacik I, Yewdell JW, Behrens TW, Bennink Jr. Promiscuous liberation of MHC-class I-binding peptides from the C termini of membrane and soluble proteins in the secretory pathway. Eur. J. Immunol. 28(4), 1339-1346 (1998).
    • (1998) Eur. J. Immunol , vol.28 , Issue.4 , pp. 1339-1346
    • Snyder, H.L.1    Bacik, I.2    Yewdell, J.W.3    Behrens, T.W.4    Bennink, J.R.5
  • 71
    • 0034280526 scopus 로고    scopus 로고
    • The ubiquitin system and the N-end rule pathway
    • Varshavsky A, Turner G, Du FY, Xie YM. The ubiquitin system and the N-end rule pathway. Biol. Chem. 381(9-10), 779-789 (2000).
    • (2000) Biol. Chem , vol.381 , Issue.9-10 , pp. 779-789
    • Varshavsky, A.1    Turner, G.2    Du, F.Y.3    Xie, Y.M.4
  • 72
    • 0025900181 scopus 로고
    • Efficient processing of an antigenic sequence for presentation by mhc class-i molecules depends on its neighboring residues in the protein
    • Delval M, Schlicht HJ, Ruppert T, Reddehase MJ, Koszinowski UH. Efficient processing of an antigenic sequence for presentation by mhc class-i molecules depends on its neighboring residues in the protein. Cell 66(6), 1145-1153 (1991).
    • (1991) Cell , vol.66 , Issue.6 , pp. 1145-1153
    • Delval, M.1    Schlicht, H.J.2    Ruppert, T.3    Reddehase, M.J.4    Koszinowski, U.H.5
  • 73
    • 0033120573 scopus 로고    scopus 로고
    • Utilization of MHC class i transgenic mice for development of minigene DNA vaccines encoding multiple HLA-restricted CTL epitopes
    • Ishioka GY, Fikes J, Hermanson G et al. Utilization of MHC class I transgenic mice for development of minigene DNA vaccines encoding multiple HLA-restricted CTL epitopes. J. Immunol. 162(7), 3915-3925 (1999).
    • (1999) J. Immunol , vol.162 , Issue.7 , pp. 3915-3925
    • Ishioka, G.Y.1    Fikes, J.2    Hermanson, G.3
  • 75
    • 0035860626 scopus 로고    scopus 로고
    • Optimization of epitope processing enhances immunogenicity of multiepitope DNA vaccines
    • Livingston BD, Newman M, Crimi C, Mckinney D, Chesnut R, Sette A. Optimization of epitope processing enhances immunogenicity of multiepitope DNA vaccines. Vaccine 19(32), 4652-4660 (2001).
    • (2001) Vaccine , vol.19 , Issue.32 , pp. 4652-4660
    • Livingston, B.D.1    Newman, M.2    Crimi, C.3    McKinney, D.4    Chesnut, R.5    Sette, A.6
  • 76
    • 0033118158 scopus 로고    scopus 로고
    • Specificity of the proteasome and the TAP transporter
    • Uebel S, Tampe R. Specificity of the proteasome and the TAP transporter. Curr. Opin. Immunol. 11(2), 203-208 (1999).
    • (1999) Curr. Opin. Immunol , vol.11 , Issue.2 , pp. 203-208
    • Uebel, S.1    Tampe, R.2
  • 77
    • 0041589474 scopus 로고    scopus 로고
    • Identifying MHC class i epitopes by predicting the TAP transport efficiency of epitope precursors
    • Peters B, Bulik S, Tampe R, Van Endert PM, Holzhutter HG. Identifying MHC class I epitopes by predicting the TAP transport efficiency of epitope precursors. J. Immunol. 171(4), 1741-1749 (2003).
    • (2003) J. Immunol , vol.171 , Issue.4 , pp. 1741-1749
    • Peters, B.1    Bulik, S.2    Tampe, R.3    Van Endert, P.M.4    Holzhutter, H.G.5
  • 78
    • 70349777629 scopus 로고    scopus 로고
    • Design of a HIV-1-derived HLA-B07.02-restricted polyepitope construct
    • Cardinaud S, Bouziat R, Rohrlich PS et al. Design of a HIV-1-derived HLA-B07.02-restricted polyepitope construct. AIDS 23(15), 1945-1954 (2009).
    • (2009) AIDS , vol.23 , Issue.15 , pp. 1945-1954
    • Cardinaud, S.1    Bouziat, R.2    Rohrlich, P.S.3
  • 79
    • 0034235311 scopus 로고    scopus 로고
    • Cutting edge: Introduction of an endopeptidase cleavage motif into a determinant flanking region of hen egg lysozyme results in enhanced T cell determinant display
    • Schneider SC, Ohmen J, Fosdick L et al. Cutting edge: Introduction of an endopeptidase cleavage motif into a determinant flanking region of hen egg lysozyme results in enhanced T cell determinant display. J. Immunol. 165(1), 20-23 (2000).
    • (2000) J. Immunol , vol.165 , Issue.1 , pp. 20-23
    • Schneider, S.C.1    Ohmen, J.2    Fosdick, L.3
  • 80
    • 23444450284 scopus 로고    scopus 로고
    • Insertion of the dibasic motif in the flanking region of a cryptic self-determinant leads to activation of the epitope-specific T cells
    • Zhu H, Liu KC, Cerny J, Imoto T, Moudgil KD. Insertion of the dibasic motif in the flanking region of a cryptic self-determinant leads to activation of the epitope-specific T cells. J. Immunol. 175(4), 2252-2260 (2005).
    • (2005) J. Immunol , vol.175 , Issue.4 , pp. 2252-2260
    • Zhu, H.1    Liu, K.C.2    Cerny, J.3    Imoto, T.4    Moudgil, K.D.5
  • 81
    • 0029151298 scopus 로고
    • Lysosome-associated membrane protein-1-mediated targeting of the HIV-1 envelope protein to an endosomal/ lysosomal compartment enhances its presentation to mhc class ii-restricted T-cells
    • Rowell JF, Ruff AL, Guarnieri FG et al. Lysosome-associated membrane protein-1-mediated targeting of the HIV-1 envelope protein to an endosomal/ lysosomal compartment enhances its presentation to mhc class ii-restricted T-cells. J. Immunol. 155(4), 1818-1828 (1995).
    • (1995) J. Immunol , vol.155 , Issue.4 , pp. 1818-1828
    • Rowell, J.F.1    Ruff, A.L.2    Guarnieri, F.G.3
  • 82
    • 0030929333 scopus 로고    scopus 로고
    • The enhanced immune response to the HIV gp160/LAMP chimeric gene product targeted to the lysosome membrane protein trafficking pathway
    • Ruff AL, Guarnieri FG, Staveleyocarroll K, Siliciano RF, August JT. The enhanced immune response to the HIV gp160/LAMP chimeric gene product targeted to the lysosome membrane protein trafficking pathway. J. Biol. Chem. 272(13), 8671-8678 (1997).
    • (1997) J. Biol. Chem , vol.272 , Issue.13 , pp. 8671-8678
    • Ruff, A.L.1    Guarnieri, F.G.2    Staveleyocarroll, K.3    Siliciano, R.F.4    August, J.T.5
  • 83
    • 0029583864 scopus 로고
    • Engineering an intracellular pathway for major histocompatibility complex class-ii presentation of antigens
    • Wu TC, Guarnieri FG, Staveleyocarroll KF et al. Engineering an intracellular pathway for major histocompatibility complex class-ii presentation of antigens. Proc. Natl Acad. Sci. USA 92(25), 11671-11675 (1995).
    • (1995) Proc. Natl Acad. Sci. USA , vol.92 , Issue.25 , pp. 11671-11675
    • Wu, T.C.1    Guarnieri, F.G.2    Staveleyocarroll, K.F.3
  • 84
    • 0027396163 scopus 로고
    • The motif TYR-X-Xhydrophobic residue mediates lysosomal membrane targeting of lysosome-associated membrane protein-1
    • Guarnieri FG, Arterburn LM, Penno MB, Cha Y, August JT. The motif TYR-X-Xhydrophobic residue mediates lysosomal membrane targeting of lysosome-associated membrane protein-1. J. Biol. Chem. 268(3), 1941-1946 (1993).
    • (1993) J. Biol. Chem , vol.268 , Issue.3 , pp. 1941-1946
    • Guarnieri, F.G.1    Arterburn, L.M.2    Penno, M.B.3    Cha, Y.4    August, J.T.5
  • 85
    • 34848813798 scopus 로고    scopus 로고
    • A synergistic effect of a combined bivalent DNA-protein anti-HIV-I vaccine containing multiple T-and B-cell epitopes of HIV-1 proteins
    • Bazhan SI, Karpenko LI, Lebedev LR et al. A synergistic effect of a combined bivalent DNA-protein anti-HIV-I vaccine containing multiple T-and B-cell epitopes of HIV-1 proteins. Mol. Immunol. 45(3), 661-669 (2008).
    • (2008) Mol. Immunol , vol.45 , Issue.3 , pp. 661-669
    • Bazhan, S.I.1    Karpenko, L.I.2    Lebedev, L.R.3
  • 86
    • 2442689202 scopus 로고    scopus 로고
    • Messenger RNA-electroporated dendritic cells presenting MAGE-A3 simultaneously in HLA class i and class II molecules
    • Bonehill A, Heirman C, Tuyaerts S et al. Messenger RNA-electroporated dendritic cells presenting MAGE-A3 simultaneously in HLA class I and class II molecules. J. Immunol. 172(11), 6649-6657 (2004).
    • (2004) J. Immunol , vol.172 , Issue.11 , pp. 6649-6657
    • Bonehill, A.1    Heirman, C.2    Tuyaerts, S.3
  • 87
    • 0035871844 scopus 로고    scopus 로고
    • Targeting antigen in mature dendritic cells for simultaneous stimulation of CD4(+) and CD8(+) T cells
    • Bonini C, Lee SP, Riddell SR, Greenberg PD. Targeting antigen in mature dendritic cells for simultaneous stimulation of CD4(+) and CD8(+) T cells. J. Immunol. 166(8), 5250-5257 (2001).
    • (2001) J. Immunol , vol.166 , Issue.8 , pp. 5250-5257
    • Bonini, C.1    Lee, S.P.2    Riddell, S.R.3    Greenberg, P.D.4
  • 88
    • 23044481201 scopus 로고    scopus 로고
    • Induction of CD4(+) and CD8(+) T-cell responses to the human stroma antigen, fibroblast activation protein: Implication for cancer immunotherapy
    • Fassnacht M, Lee J, Milazzo C et al. Induction of CD4(+) and CD8(+) T-cell responses to the human stroma antigen, fibroblast activation protein: Implication for cancer immunotherapy. Clin. Cancer Res. 11(15), 5566-5571 (2005).
    • (2005) Clin. Cancer Res , vol.11 , Issue.15 , pp. 5566-5571
    • Fassnacht, M.1    Lee, J.2    Milazzo, C.3
  • 89
    • 0041331718 scopus 로고    scopus 로고
    • Enhancing DNA vaccine potency by combining a strategy to prolong dendritic cell life with intracellular targeting strategies
    • Kim TW, Hung CF, Boyd D et al. Enhancing DNA vaccine potency by combining a strategy to prolong dendritic cell life with intracellular targeting strategies. J. Immunol. 171(6), 2970-2976 (2003).
    • (2003) J. Immunol , vol.171 , Issue.6 , pp. 2970-2976
    • Kim, T.W.1    Hung, C.F.2    Boyd, D.3
  • 90
    • 0036735405 scopus 로고    scopus 로고
    • Enhanced induction of telomerase-specific CD4(+) T cells using dendritic cells transfected with RNA encoding a chimeric gene product
    • Su Z, Vieweg J, Weizer AZ et al. Enhanced induction of telomerase-specific CD4(+) T cells using dendritic cells transfected with RNA encoding a chimeric gene product. Cancer Res. 62(17), 5041-5048 (2002).
    • (2002) Cancer Res , vol.62 , Issue.17 , pp. 5041-5048
    • Su, Z.1    Vieweg, J.2    Weizer, A.Z.3
  • 91
    • 0031906148 scopus 로고    scopus 로고
    • Increased immune response elicited by DNA vaccination with a synthetic gp120 sequence with optimized codon usage
    • Andre S, Seed B, Eberle J, Schraut W, Bultmann A, Haas J. Increased immune response elicited by DNA vaccination with a synthetic gp120 sequence with optimized codon usage. J. Virol. 72(2), 1497-1503 (1998).
    • (1998) J. Virol , vol.72 , Issue.2 , pp. 1497-1503
    • Andre, S.1    Seed, B.2    Eberle, J.3    Schraut, W.4    Bultmann, A.5    Haas, J.6
  • 92
    • 0034755765 scopus 로고    scopus 로고
    • Multiple effects of codon usage optimization on expression and immunogenicity of DNA candidate vaccines encoding the human immunodeficiency virus type 1 Gag protein
    • Deml L, Bojak A, Steck S et al. Multiple effects of codon usage optimization on expression and immunogenicity of DNA candidate vaccines encoding the human immunodeficiency virus type 1 Gag protein. J. Virol. 75(22), 10991-11001 (2001).
    • (2001) J. Virol , vol.75 , Issue.22 , pp. 10991-11001
    • Deml, L.1    Bojak, A.2    Steck, S.3
  • 93
    • 34250176485 scopus 로고    scopus 로고
    • A quantitative analysis of the variables affecting the repertoire of T cell specificities recognized after vaccinia virus infection
    • Assarsson E, Sidney J, Oseroff C et al. A quantitative analysis of the variables affecting the repertoire of T cell specificities recognized after vaccinia virus infection. J. Immunol. 178(12), 7890-7901 (2007).
    • (2007) J. Immunol , vol.178 , Issue.12 , pp. 7890-7901
    • Assarsson, E.1    Sidney, J.2    Oseroff, C.3
  • 94
    • 83155164579 scopus 로고    scopus 로고
    • Predictions versus high-throughput experiments in T-cell epitope discovery: Competition or synergy?
    • Lundegaard C, Lund O, Nielsen M. Predictions versus high-throughput experiments in T-cell epitope discovery: competition or synergy? Exp. Rev. Vaccin. 11(1), 43-54 (2012).
    • (2012) Exp. Rev. Vaccin , vol.11 , Issue.1 , pp. 43-54
    • Lundegaard, C.1    Lund, O.2    Nielsen, M.3
  • 95
    • 83155180577 scopus 로고    scopus 로고
    • Toward more accurate pan-specific MHC-peptide binding prediction: A review of current methods and tools
    • Zhang LM, Udaka K, Mamitsuka H, Zhu SF. Toward more accurate pan-specific MHC-peptide binding prediction: a review of current methods and tools. Brief. Bioinform. 13(3), 350-364 (2012).
    • (2012) Brief. Bioinform , vol.13 , Issue.3 , pp. 350-364
    • Zhang, L.M.1    Udaka, K.2    Mamitsuka, H.3    Zhu, S.F.4
  • 96
    • 77953496862 scopus 로고    scopus 로고
    • Major histocompatibility complex class i binding predictions as a tool in epitope discovery
    • Lundegaard C, Lund O, Buus S, Nielsen M. Major histocompatibility complex class I binding predictions as a tool in epitope discovery. Immunology 130(3), 309-318 (2010).
    • (2010) Immunology , vol.130 , Issue.3 , pp. 309-318
    • Lundegaard, C.1    Lund, O.2    Buus, S.3    Nielsen, M.4
  • 97
    • 70449416038 scopus 로고    scopus 로고
    • Prediction of MHC-peptide binding: A systematic and comprehensive overview
    • Lafuente EM, Reche PA. Prediction of MHC-peptide binding: a systematic and comprehensive overview. Curr. Pharm. Design 15(28), 3209-3220 (2009).
    • (2009) Curr. Pharm. Design , vol.15 , Issue.28 , pp. 3209-3220
    • Lafuente, E.M.1    Reche, P.A.2
  • 98
    • 32444438223 scopus 로고    scopus 로고
    • ProPred analysis and experimental evaluation of promiscuous T-cell epitopes of three major secreted antigens of Mycobacterium tuberculosis
    • Mustafa AS, Shaban FA. ProPred analysis and experimental evaluation of promiscuous T-cell epitopes of three major secreted antigens of Mycobacterium tuberculosis. Tuberculosis 86(2), 115-124 (2006).
    • (2006) Tuberculosis , vol.86 , Issue.2 , pp. 115-124
    • Mustafa, A.S.1    Shaban, F.A.2
  • 99
    • 33744810308 scopus 로고    scopus 로고
    • Immunogenic HLA-B 0702-restricted epitopes derived from human telomerase reverse transcriptase that elicit antitumor cytotoxic T-cell responses
    • Adotevi O, Mollier K, Neuveut C et al. Immunogenic HLA-B 0702-restricted epitopes derived from human telomerase reverse transcriptase that elicit antitumor cytotoxic T-cell responses. Clin. Cancer Res. 12(10), 3158-3167 (2006).
    • (2006) Clin. Cancer Res , vol.12 , Issue.10 , pp. 3158-3167
    • Adotevi, O.1    Mollier, K.2    Neuveut, C.3
  • 100
    • 33645223267 scopus 로고    scopus 로고
    • Identitication of a new HLA-A2-restricted T-cell epitope within HM1.24 as immunotherapy target for multiple myeloma
    • Hunderner M, Schmidt S, Condomines M et al. Identitication of a new HLA-A2-restricted T-cell epitope within HM1.24 as immunotherapy target for multiple myeloma. Exp. Hematol. 34(4), 486-496 (2006).
    • (2006) Exp. Hematol , vol.34 , Issue.4 , pp. 486-496
    • Hunderner, M.1    Schmidt, S.2    Condomines, M.3
  • 101
    • 33947588271 scopus 로고    scopus 로고
    • Computational prediction and identification of HLA-A2.1-specific Ebola virus CTL epitopes
    • Sundar K, Boesen A, Coico R. Computational prediction and identification of HLA-A2.1-specific Ebola virus CTL epitopes. Virology 360(2), 257-263 (2007).
    • (2007) Virology , vol.360 , Issue.2 , pp. 257-263
    • Sundar, K.1    Boesen, A.2    Coico, R.3
  • 102
    • 38949200571 scopus 로고    scopus 로고
    • Computational prediction and identification of dengue virus-specific CD4 (+) T-cell epitopes
    • Wen JS, Jiang LF, Zhou JM, Yan HJ, Fang DY. Computational prediction and identification of dengue virus-specific CD4 (+) T-cell epitopes. Virus Res. 132(1-2), 42-48 (2008).
    • (2008) Virus Res , vol.132 , Issue.1-2 , pp. 42-48
    • Wen, J.S.1    Jiang, L.F.2    Zhou, J.M.3    Yan, H.J.4    Fang, D.Y.5
  • 103
    • 0025855156 scopus 로고
    • Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules
    • Falk K, Rotzschke O, Stevanovic S, Jung G, Rammensee HG. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 351(6324), 290-296 (1991).
    • (1991) Nature , vol.351 , Issue.6324 , pp. 290-296
    • Falk, K.1    Rotzschke, O.2    Stevanovic, S.3    Jung, G.4    Rammensee, H.G.5
  • 104
    • 0026010271 scopus 로고
    • Precise prediction of a dominant class-i MHCrestricted epitope of listeria-monocytogenes
    • Pamer EG, Harty JT, Bevan MJ. Precise prediction of a dominant class-i MHCrestricted epitope of listeria-monocytogenes. Nature 353(6347), 852-855 (1991).
    • (1991) Nature , vol.353 , Issue.6347 , pp. 852-855
    • Pamer, E.G.1    Harty, J.T.2    Bevan, M.J.3
  • 106
    • 0037606124 scopus 로고    scopus 로고
    • ProPred1: Prediction of promiscuous MHC Class-I binding sites
    • Singh H, Raghava GPS. ProPred1: prediction of promiscuous MHC Class-I binding sites. Bioinformatics 19(8), 1009-1014 (2003).
    • (2003) Bioinformatics , vol.19 , Issue.8 , pp. 1009-1014
    • Singh, H.1    Raghava, G.P.S.2
  • 108
    • 5444249860 scopus 로고    scopus 로고
    • Enhancement to the RANKPEP resource for the prediction of peptide binding to MHC molecules using profiles
    • Reche PA, Glutting JP, Zhang H, Reinherz EL. Enhancement to the RANKPEP resource for the prediction of peptide binding to MHC molecules using profiles. Immunogenetics 56(6), 405-419 (2004).
    • (2004) Immunogenetics , vol.56 , Issue.6 , pp. 405-419
    • Reche, P.A.1    Glutting, J.P.2    Zhang, H.3    Reinherz, E.L.4
  • 109
    • 0142174642 scopus 로고    scopus 로고
    • Prediction of MHC class i binding peptides, using SVMHC
    • Donnes P, Elofsson A. Prediction of MHC class I binding peptides, using SVMHC. BMC Bioinformatics 3, 25 (2002).
    • (2002) BMC Bioinformatics , vol.3 , pp. 25
    • Donnes, P.1    Elofsson, A.2
  • 110
    • 2442499729 scopus 로고    scopus 로고
    • Improved prediction of MHC class i and class II epitopes using a novel Gibbs sampling approach
    • Nielsen M, Lundegaard C, Worning P et al. Improved prediction of MHC class I and class II epitopes using a novel Gibbs sampling approach. Bioinformatics 20(9), 1388-1397 (2004).
    • (2004) Bioinformatics , vol.20 , Issue.9 , pp. 1388-1397
    • Nielsen, M.1    Lundegaard, C.2    Worning, P.3
  • 112
    • 79957628239 scopus 로고    scopus 로고
    • Predicting peptide binding to Major Histocompatibility Complex molecules
    • Liao WWP, Arthur JW. Predicting peptide binding to Major Histocompatibility Complex molecules. Autoimmun. Rev. 10(8), 469-473 (2011).
    • (2011) Autoimmun. Rev , vol.10 , Issue.8 , pp. 469-473
    • Wwp, L.1    Arthur, J.W.2
  • 113
    • 84877780179 scopus 로고    scopus 로고
    • T-cell epitope vaccine design by immunoinformatics
    • Patronov A, Doytchinova I. T-cell epitope vaccine design by immunoinformatics. Open Biol. 3(2013).
    • (2013) Open Biol , vol.3
    • Patronov, A.1    Doytchinova, I.2
  • 115
    • 0028052724 scopus 로고
    • Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains
    • Parker KC, Bednarek MA, Coligan JE. Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J. Immunol. 152(1), 163-175 (1994).
    • (1994) J. Immunol , vol.152 , Issue.1 , pp. 163-175
    • Parker, K.C.1    Bednarek, M.A.2    Coligan, J.E.3
  • 116
    • 0033021020 scopus 로고    scopus 로고
    • Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices
    • Sturniolo T, Bono E, Ding JY et al. Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices. Nat. Biotechnol. 17(6), 555-561 (1999).
    • (1999) Nat. Biotechnol , vol.17 , Issue.6 , pp. 555-561
    • Sturniolo, T.1    Bono, E.2    Ding, J.Y.3
  • 117
    • 0141617555 scopus 로고    scopus 로고
    • Examining the independent binding assumption for binding of peptide epitopes to MHC-1 molecules
    • Peters B, Tong WW, Sidney J, Sette A, Weng ZP. Examining the independent binding assumption for binding of peptide epitopes to MHC-1 molecules. Bioinformatics 19(14), 1765-1772 (2003).
    • (2003) Bioinformatics , vol.19 , Issue.14 , pp. 1765-1772
    • Peters, B.1    Tong, W.W.2    Sidney, J.3    Sette, A.4    Weng, Z.P.5
  • 118
    • 84919841070 scopus 로고    scopus 로고
    • Empirical AI, and QSAR Approaches to Peptide-MHC Binding Prediction
    • Timmis DFJ (Ed.) Springer US
    • Hattotuwagama CEA. Empirical, AI, and QSAR Approaches to Peptide-MHC Binding Prediction. In: In Silico Immunology SE. Timmis DFJ (Ed. Springer US, 139-175 (2007).
    • (2007) Silico Immunology SE , pp. 139-175
    • Cea, H.1
  • 119
    • 77950352237 scopus 로고    scopus 로고
    • TEpredict: Software for T-Cell epitope prediction
    • Antonets DV, Maksyutov AZ. TEpredict: Software for T-Cell epitope prediction. Mol. Biol. 44(1), 119-127 (2010).
    • (2010) Mol. Biol , vol.44 , Issue.1 , pp. 119-127
    • Antonets, D.V.1    Maksyutov, A.Z.2
  • 121
    • 78651292217 scopus 로고    scopus 로고
    • Allele frequency net: A database and online repository for immune gene frequencies in worldwide populations
    • Gonzalez-Galarza FF, Christmas S, Middleton D, Jones AR. Allele frequency net: a database and online repository for immune gene frequencies in worldwide populations. Nucleic Acids Res. 39, D913-D919 (2011).
    • (2011) Nucleic Acids Res , vol.39
    • Gonzalez-Galarza, F.F.1    Christmas, S.2    Middleton, D.3    Jones, A.R.4
  • 122
    • 20944447214 scopus 로고    scopus 로고
    • The immune epitope database and analysis resource: From vision to blueprint
    • Peters B, Sidney J, Bourne P et al. The immune epitope database and analysis resource: From vision to blueprint. PLoS Biol. 3(3), 379-381 (2005).
    • (2005) PLoS Biol , vol.3 , Issue.3 , pp. 379-381
    • Peters, B.1    Sidney, J.2    Bourne, P.3
  • 123
    • 0032146234 scopus 로고    scopus 로고
    • HLA supertypes and supermotifs: A functional perspective on HLA polymorphism
    • Sette A, Sidney J. HLA supertypes and supermotifs: a functional perspective on HLA polymorphism. Curr. Opin. Immunol. 10(4), 478-482 (1998).
    • (1998) Curr. Opin. Immunol , vol.10 , Issue.4 , pp. 478-482
    • Sette, A.1    Sidney, J.2
  • 124
    • 0033388724 scopus 로고    scopus 로고
    • Nine major HLA class i supertypes account for the vast preponderance of HLA-A and -B polymorphism
    • Sette A, Sidney J. Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism. Immunogenetics 50(3-4), 201-212 (1999).
    • (1999) Immunogenetics , vol.50 , Issue.3-4 , pp. 201-212
    • Sette, A.1    Sidney, J.2
  • 125
    • 18944395866 scopus 로고    scopus 로고
    • In silico identification of supertypes for class II MHCs
    • Doytchinova IA, Flower DR. In silico identification of supertypes for class II MHCs. J. Immunol. 174(11), 7085-7095 (2005).
    • (2005) J. Immunol , vol.174 , Issue.11 , pp. 7085-7095
    • Doytchinova, I.A.1    Flower, D.R.2
  • 127
    • 18544370572 scopus 로고    scopus 로고
    • Optimizing vaccine design for cellular processing, MHC binding and TCR recognition
    • Sette A, Newman M, Livingston B et al. Optimizing vaccine design for cellular processing, MHC binding and TCR recognition. Tissue Antigens 59(6), 443-451 (2002).
    • (2002) Tissue Antigens , vol.59 , Issue.6 , pp. 443-451
    • Sette, A.1    Newman, M.2    Livingston, B.3
  • 128
    • 0041402836 scopus 로고    scopus 로고
    • Epitope-based vaccines: An update on epitope identification, vaccine design and delivery
    • Sette A, Fikes J. Epitope-based vaccines: an update on epitope identification, vaccine design and delivery. Curr. Opin. Immunol. 15(4), 461-470 (2003).
    • (2003) Curr. Opin. Immunol , vol.15 , Issue.4 , pp. 461-470
    • Sette, A.1    Fikes, J.2
  • 129
    • 77956217622 scopus 로고    scopus 로고
    • A Vaccine Encoding Conserved Promiscuous HIV CD4 Epitopes Induces Broad T Cell Responses in Mice Transgenic to Multiple Common HLA Class II Molecules
    • Ribeiro SP, Rosa DS, Fonseca SG et al. A Vaccine Encoding Conserved Promiscuous HIV CD4 Epitopes Induces Broad T Cell Responses in Mice Transgenic to Multiple Common HLA Class II Molecules. PLoS ONE 5(6) (2010).
    • (2010) PLoS ONE , vol.5 , Issue.6
    • Ribeiro, S.P.1    Rosa, D.S.2    Fonseca, S.G.3
  • 130
    • 48249083459 scopus 로고    scopus 로고
    • Quantitative Predictions of Peptide Binding to Any HLA-DR Molecule of Known Sequence: NetMHCIIpan
    • Nielsen M, Lundegaard C, Blicher T et al. Quantitative Predictions of Peptide Binding to Any HLA-DR Molecule of Known Sequence: NetMHCIIpan. PLoS Comput. Biol. 4(7) (2008).
    • (2008) PLoS Comput. Biol , vol.4 , Issue.7
    • Nielsen, M.1    Lundegaard, C.2    Blicher, T.3
  • 131
    • 0035796461 scopus 로고    scopus 로고
    • Discrete cleavage motifs of constitutive and immunoproteasomes revealed by quantitative analysis of cleavage products
    • Toes REM, Nussbaum AK, Degermann S et al. Discrete cleavage motifs of constitutive and immunoproteasomes revealed by quantitative analysis of cleavage products. J. Exp. Med. 194(1), 1-12 (2001).
    • (2001) J. Exp. Med , vol.194 , Issue.1 , pp. 1-12
    • Rem, T.1    Nussbaum, A.K.2    Degermann, S.3
  • 132
    • 1642407844 scopus 로고    scopus 로고
    • Identifiying human MHC supertypes using bioinformatic methods
    • Doytchinova IA, Guan PP, Flower DR. Identifiying human MHC supertypes using bioinformatic methods. J. Immunol. 172(7), 4314-4323 (2004).
    • (2004) J. Immunol , vol.172 , Issue.7 , pp. 4314-4323
    • Doytchinova, I.A.1    Guan, P.P.2    Flower, D.R.3
  • 133
    • 80051664115 scopus 로고    scopus 로고
    • Characterization of the binding profile of peptide to transporter associated with antigen processing (TAP) using Gaussian process regression
    • Ren YG, Wu B, Pan YZ et al. Characterization of the binding profile of peptide to transporter associated with antigen processing (TAP) using Gaussian process regression. Comput. Biol. Med. 41(9), 865-870 (2011).
    • (2011) Comput. Biol. Med , vol.41 , Issue.9 , pp. 865-870
    • Ren, Y.G.1    Wu, B.2    Pan, Y.Z.3
  • 135
    • 33745584371 scopus 로고    scopus 로고
    • A community resource benchmarking predictions of peptide binding to MHC-I molecules
    • Peters B, Bui HH, Frankild S et al. A community resource benchmarking predictions of peptide binding to MHC-I molecules. PLoS Comput. Biol. 2(6), 574-584 (2006).
    • (2006) PLoS Comput. Biol , vol.2 , Issue.6 , pp. 574-584
    • Peters, B.1    Bui, H.H.2    Frankild, S.3
  • 136
    • 57649174707 scopus 로고    scopus 로고
    • Evaluation of MHC class i peptide binding prediction servers: Applications for vaccine research
    • Lin HH, Ray S, Tongchusak S, Reinherz EL, Brusic V. Evaluation of MHC class I peptide binding prediction servers: Applications for vaccine research. BMC Immunol. 9(2008).
    • (2008) BMC Immunol , vol.9
    • Lin, H.H.1    Ray, S.2    Tongchusak, S.3    Reinherz, E.L.4    Brusic, V.5
  • 137
    • 33746132748 scopus 로고    scopus 로고
    • A consensus epitope prediction approach identifies the breadth of murine TCD8+-cell responses to vaccinia virus
    • Moutaftsi M, Peters B, Pasquetto V et al. A consensus epitope prediction approach identifies the breadth of murine TCD8+-cell responses to vaccinia virus. Nat. Biotechnol. 24(7), 817-819 (2006).
    • (2006) Nat. Biotechnol , vol.24 , Issue.7 , pp. 817-819
    • Moutaftsi, M.1    Peters, B.2    Pasquetto, V.3
  • 138
    • 23844528191 scopus 로고    scopus 로고
    • An integrative approach to CTL epitope prediction: A combined algorithm integrating MHC class i binding, TAP transport efficiency, and proteasomal cleavage predictions
    • Larsen MV, Lundegaard C, Lamberth K et al. An integrative approach to CTL epitope prediction: A combined algorithm integrating MHC class I binding, TAP transport efficiency, and proteasomal cleavage predictions. Eur. J. Immunol. 35(8), 2295-2303 (2005).
    • (2005) Eur. J. Immunol , vol.35 , Issue.8 , pp. 2295-2303
    • Larsen, M.V.1    Lundegaard, C.2    Lamberth, K.3
  • 139
    • 77953149616 scopus 로고    scopus 로고
    • NetCTLpan: Pan-specific MHC class i pathway epitope predictions
    • Stranzl T, Larsen MV, Lundegaard C, Nielsen M. NetCTLpan: pan-specific MHC class I pathway epitope predictions. Immunogenetics 62(6), 357-368 (2010).
    • (2010) Immunogenetics , vol.62 , Issue.6 , pp. 357-368
    • Stranzl, T.1    Larsen, M.V.2    Lundegaard, C.3    Nielsen, M.4
  • 140
    • 79958045785 scopus 로고    scopus 로고
    • Protective efficacy of serially up-ranked subdominant CD8(+) T cell epitopes against virus challenges
    • Im EJ, Hong JP, Roshorm Y et al. Protective efficacy of serially up-ranked subdominant CD8(+) T cell epitopes against virus challenges. PLoS Pathog. 7(5)(2011).
    • (2011) PLoS Pathog , vol.7 , Issue.5
    • Im, E.J.1    Hong, J.P.2    Roshorm, Y.3
  • 142
    • 84877113687 scopus 로고    scopus 로고
    • Discovering naturally processed antigenic determinants that confer protective T cell immunity
    • Gilchuk P, Spencer CT, Conant SB et al. Discovering naturally processed antigenic determinants that confer protective T cell immunity. J. Clin. Invest. 123(5), 1976-1987 (2013).
    • (2013) J. Clin. Invest , vol.123 , Issue.5 , pp. 1976-1987
    • Gilchuk, P.1    Spencer, C.T.2    Conant, S.B.3
  • 143
    • 70249106764 scopus 로고    scopus 로고
    • Rational optimization of tumor epitopes using in silico analysis-assisted substitution of TCR contact residues
    • Shang XY, Wang L, Niu W et al. Rational optimization of tumor epitopes using in silico analysis-assisted substitution of TCR contact residues. Eur. J. Immunol. 39(8), 2248-2258 (2009).
    • (2009) Eur. J. Immunol , vol.39 , Issue.8 , pp. 2248-2258
    • Shang, X.Y.1    Wang, L.2    Niu, W.3
  • 144
    • 84856913522 scopus 로고    scopus 로고
    • For protection from HIV-1 infection, more might not be better: A systematic analysis of HIV gag epitopes of two alleles associated with different outcomes of HIV-1 infection
    • Luo M, Daniuk CA, Diallo TO et al. For protection from HIV-1 infection, more might not be better: a systematic analysis of HIV gag epitopes of two alleles associated with different outcomes of HIV-1 infection. J. Virol. 86(2), 1166-1180 (2012).
    • (2012) J. Virol , vol.86 , Issue.2 , pp. 1166-1180
    • Luo, M.1    Daniuk, C.A.2    Diallo, T.O.3
  • 145
    • 84875546274 scopus 로고    scopus 로고
    • Translating HIV sequences into quantitative fitness landscapes predicts viral vulnerabilities for rational immunogen design
    • Ferguson ALEA. Translating HIV sequences into quantitative fitness landscapes predicts viral vulnerabilities for rational immunogen design. Immunity 38(3), 606-617 (2013).
    • (2013) Immunity , vol.38 , Issue.3 , pp. 606-617
    • Ferguson, A.L.E.A.1
  • 146
    • 84865630094 scopus 로고    scopus 로고
    • Increasing the efficacy of tumor cell vaccines by enhancing cross priming
    • Andersen BM, Ohlfest Jr. Increasing the efficacy of tumor cell vaccines by enhancing cross priming. Cancer Lett. 325(2), 155-164 (2012).
    • (2012) Cancer Lett , vol.325 , Issue.2 , pp. 155-164
    • Andersen, B.M.1    Ohlfest, J.R.2
  • 147
    • 84855735425 scopus 로고    scopus 로고
    • Epitope-driven DNA vaccine design employing immunoinformatics against B-cell lymphoma: A biotech's challenge
    • Iurescia S, Fioretti D, Fazio VM, Rinaldi M. Epitope-driven DNA vaccine design employing immunoinformatics against B-cell lymphoma: A biotech's challenge. Biotechnol. Adv. 30(1), 372-383 (2012).
    • (2012) Biotechnol. Adv , vol.30 , Issue.1 , pp. 372-383
    • Iurescia, S.1    Fioretti, D.2    Fazio, V.M.3    Rinaldi, M.4
  • 148
    • 0029152771 scopus 로고
    • Amino-terminal alteration of the HLA-Aasterisk-0201-restricted human-immunodeficiency-virus pol peptide increases complex stability and in-vitro immunogenicity
    • Pogue RR, Eron J, Frelinger JA, Matsui M. Amino-terminal alteration of the HLA-Aasterisk-0201-restricted human-immunodeficiency-virus pol peptide increases complex stability and in-vitro immunogenicity. Proc. Natl Acad. Sci. USA 92(18), 8166-8170 (1995).
    • (1995) Proc. Natl Acad. Sci. USA , vol.92 , Issue.18 , pp. 8166-8170
    • Pogue, R.R.1    Eron, J.2    Frelinger, J.A.3    Matsui, M.4
  • 149
    • 0035903287 scopus 로고    scopus 로고
    • Structural features of peptide analogs of human histocompatibility leukocyte antigen class i epitopes that are more potent and immunogenic than wild-type peptide
    • Tangri S, Ishioka GY, Huang XQ et al. Structural features of peptide analogs of human histocompatibility leukocyte antigen class I epitopes that are more potent and immunogenic than wild-type peptide. J. Exp. Med. 194(6), 833-846 (2001).
    • (2001) J. Exp. Med , vol.194 , Issue.6 , pp. 833-846
    • Tangri, S.1    Ishioka, G.Y.2    Huang, X.Q.3
  • 150
    • 0026502327 scopus 로고
    • Induction of broadly cross-reactive cytotoxic t-cells recognizing an HIV-1 envelope determinant
    • Takahashi H, Nakagawa Y, Pendleton CD et al. Induction of broadly cross-reactive cytotoxic t-cells recognizing an HIV-1 envelope determinant. Science 255(5042), 333-336 (1992).
    • (1992) Science , vol.255 , Issue.5042 , pp. 333-336
    • Takahashi, H.1    Nakagawa, Y.2    Pendleton, C.D.3
  • 151
    • 34249328486 scopus 로고    scopus 로고
    • Lentiviral vectors encoding HIV-1 polyepitopes induce broad CTL responses in vivo
    • Iglesias MC, Mollier K, Beignon AS et al. Lentiviral vectors encoding HIV-1 polyepitopes induce broad CTL responses in vivo. Mol. Ther. 15(6), 1203-1210 (2007).
    • (2007) Mol. Ther , vol.15 , Issue.6 , pp. 1203-1210
    • Iglesias, M.C.1    Mollier, K.2    Beignon, A.S.3
  • 152
    • 0035671931 scopus 로고    scopus 로고
    • Human dendritic cells genetically engineered to express a melanoma polyepitope DNA vaccine induce multiple cytotoxic T-cell responses
    • Smith SG, Patel PM, Porte J, Selby PJ, Jackson AM. Human dendritic cells genetically engineered to express a melanoma polyepitope DNA vaccine induce multiple cytotoxic T-cell responses. Clin. Cancer Res. 7(12), 4253-4261 (2001).
    • (2001) Clin. Cancer Res , vol.7 , Issue.12 , pp. 4253-4261
    • Smith, S.G.1    Patel, P.M.2    Porte, J.3    Selby, P.J.4    Jackson, A.M.5
  • 153
    • 11144311953 scopus 로고    scopus 로고
    • Enhanced multiepitope-based vaccines elicit CD8(+) cytotoxic T cells against both immunodominant and cryptic epitopes
    • Tine JA, Firat H, Payne A et al. Enhanced multiepitope-based vaccines elicit CD8(+) cytotoxic T cells against both immunodominant and cryptic epitopes. Vaccine 23(8), 1085-1091 (2005).
    • (2005) Vaccine , vol.23 , Issue.8 , pp. 1085-1091
    • Tine, J.A.1    Firat, H.2    Payne, A.3
  • 154
    • 0033031413 scopus 로고    scopus 로고
    • Immunogenicity of a human immunodeficiency virus (HIV) polytope vaccine containing multiple HLA A2 HIVCD8(+) cytotoxic T-cell epitopes
    • Woodberry T, Gardner J, Mateo L et al. Immunogenicity of a human immunodeficiency virus (HIV) polytope vaccine containing multiple HLA A2 HIVCD8(+) cytotoxic T-cell epitopes. J. Virol. 73(7), 5320-5325 (1999).
    • (1999) J. Virol , vol.73 , Issue.7 , pp. 5320-5325
    • Woodberry, T.1    Gardner, J.2    Mateo, L.3
  • 155
    • 0033213988 scopus 로고    scopus 로고
    • An HLA-A2 polyepitope vaccine for melanoma immunotherapy
    • Mateo L, Gardner J, Chen QY et al. An HLA-A2 polyepitope vaccine for melanoma immunotherapy. J. Immunol. 163(7), 4058-4063 (1999).
    • (1999) J. Immunol , vol.163 , Issue.7 , pp. 4058-4063
    • Mateo, L.1    Gardner, J.2    Chen, Q.Y.3
  • 156
  • 157
    • 17844385106 scopus 로고    scopus 로고
    • The role of the proteasome in generating cytotoxic T-cell epitopes: Insights obtained from improved predictions of proteasomal cleavage
    • Nielsen M, Lundegaard C, Lund O, Kesmir C. The role of the proteasome in generating cytotoxic T-cell epitopes: insights obtained from improved predictions of proteasomal cleavage. Immunogenetics 57(1-2), 33-41 (2005).
    • (2005) Immunogenetics , vol.57 , Issue.1-2 , pp. 33-41
    • Nielsen, M.1    Lundegaard, C.2    Lund, O.3    Kesmir, C.4
  • 158
    • 9144231300 scopus 로고    scopus 로고
    • Transporter associated with antigen processing preselection of peptides binding to the MHC: A bioinformatic evaluation
    • Doytchinova I, Hemsley S, Flower DR. Transporter associated with antigen processing preselection of peptides binding to the MHC: A bioinformatic evaluation. J. Immunol. 173(11), 6813-6819 (2004).
    • (2004) J. Immunol , vol.173 , Issue.11 , pp. 6813-6819
    • Doytchinova, I.1    Hemsley, S.2    Flower, D.R.3
  • 159
    • 77952890617 scopus 로고    scopus 로고
    • Estimating design space available for polyepitopes through consideration of major histocompatibility complex binding motifs
    • Lee Y, Ferrari G, Lee SC. Estimating design space available for polyepitopes through consideration of major histocompatibility complex binding motifs. Biomed. Microdev. 12(2), 207-222 (2010).
    • (2010) Biomed. Microdev , vol.12 , Issue.2 , pp. 207-222
    • Lee, Y.1    Ferrari, G.2    Lee, S.C.3
  • 160
    • 17844386866 scopus 로고    scopus 로고
    • A CD8(+) T cell heptaepitope minigene vaccine induces protective immunity against Chlamydia pneumoniae
    • Pinchuk I, Starcher BC, Livingston B et al. A CD8(+) T cell heptaepitope minigene vaccine induces protective immunity against Chlamydia pneumoniae. J. Immunol. 174(9), 5729-5739 (2005).
    • (2005) J. Immunol , vol.174 , Issue.9 , pp. 5729-5739
    • Pinchuk, I.1    Starcher, B.C.2    Livingston, B.3
  • 161
    • 84885025604 scopus 로고    scopus 로고
    • PolyCTLDesigner: A computational tool for constructing polyepitope T-cell antigens
    • Antonets DV, Bazhan SI. PolyCTLDesigner: a computational tool for constructing polyepitope T-cell antigens. BMC Res. Notes 6(1), 407 (2013).
    • (2013) BMC Res. Notes , vol.6 , Issue.1 , pp. 407
    • Antonets, D.V.1    Bazhan, S.I.2
  • 162
    • 0036137241 scopus 로고    scopus 로고
    • ProPred: Prediction of HLA-DR binding sites
    • Singh H, Raghava GPS. ProPred: prediction of HLA-DR binding sites. Bioinformatics 17(12), 1236-1237 (2001).
    • (2001) Bioinformatics , vol.17 , Issue.12 , pp. 1236-1237
    • Singh, H.1    Raghava, G.P.S.2
  • 163
    • 84868348755 scopus 로고    scopus 로고
    • Vaccine-induced CD8(+) T cells control AIDS virus replication
    • Mudd PA, Martins MA, Ericsen AJ et al. Vaccine-induced CD8(+) T cells control AIDS virus replication. Nature 491(7422), 129-U152 (2012).
    • (2012) Nature , vol.491 , Issue.7422
    • Mudd, P.A.1    Ma, M.2    Ericsen, A.J.3
  • 164
    • 0030964959 scopus 로고    scopus 로고
    • Comparison of the oral, rectal, and vaginal immunization routes for induction of antibodies in rectal and genital tract secretions of women
    • Kozlowski PA, Cuuvin S, Neutra MR, Flanigan TP. Comparison of the oral, rectal, and vaginal immunization routes for induction of antibodies in rectal and genital tract secretions of women. Infect. Immun. 65(4), 1387-1394 (1997).
    • (1997) Infect. Immun , vol.65 , Issue.4 , pp. 1387-1394
    • Kozlowski, P.A.1    Cuuvin, S.2    Neutra, M.R.3    Flanigan, T.P.4
  • 165
    • 52449104809 scopus 로고    scopus 로고
    • DNA vaccines: Ready for prime time?
    • Kutzler MA, Weiner DB. DNA vaccines: ready for prime time? Nat. Rev. Genet. 9(10), 776-788 (2008).
    • (2008) Nat. Rev. Genet , vol.9 , Issue.10 , pp. 776-788
    • Kutzler, M.A.1    Weiner, D.B.2
  • 167
    • 80052214240 scopus 로고    scopus 로고
    • Simultaneous Approach Using Systemic, Mucosal and Transcutaneous Routes of Immunization for Development of Protective HIV-1 Vaccines
    • Belyakov IM, Ahlers JD. Simultaneous Approach Using Systemic, Mucosal and Transcutaneous Routes of Immunization For Development of Protective HIV-1 Vaccines. Current Medicinal Chemistry 18(26), 3953-3962 (2011).
    • (2011) Current Medicinal Chemistry , vol.18 , Issue.26 , pp. 3953-3962
    • Belyakov, I.M.1    Ahlers, J.D.2
  • 168
    • 84885669019 scopus 로고    scopus 로고
    • Immune clearance of highly pathogenic SIV infection
    • Hansen SG, Piatak M Jr, Ventura AB et al. Immune clearance of highly pathogenic SIV infection. Nature 502(7469), 100-104 (2013).
    • (2013) Nature , vol.502 , Issue.7469 , pp. 100-104
    • Hansen, S.G.1    Piatak Jr., M.2    Ventura, A.B.3
  • 169
    • 84877957880 scopus 로고    scopus 로고
    • Cytomegalovirus Vectors Violate CD8(+) T Cell Epitope Recognition Paradigms
    • Hansen SG, Sacha JB, Hughes CM et al. Cytomegalovirus Vectors Violate CD8(+) T Cell Epitope Recognition Paradigms. Science 340(6135), 940-+ (2013).
    • (2013) Science , vol.340 , Issue.6135
    • Hansen, S.G.1    Sacha, J.B.2    Hughes, C.M.3
  • 170
    • 84882823975 scopus 로고    scopus 로고
    • Long-term CD4(+) and CD8(+) T-cell responses induced in HIV-uninfected volunteers following intradermal or intramuscular administration of an HIV-lipopeptide vaccine (ANRS VAC16)
    • Launay O, Surenaud M, Desaint C et al. Long-term CD4(+) and CD8(+) T-cell responses induced in HIV-uninfected volunteers following intradermal or intramuscular administration of an HIV-lipopeptide vaccine (ANRS VAC16). Vaccine 31(40), 4406-4415 (2013).
    • (2013) Vaccine , vol.31 , Issue.40 , pp. 4406-4415
    • Launay, O.1    Surenaud, M.2    Desaint, C.3
  • 171
    • 84879092040 scopus 로고    scopus 로고
    • Cytokine and gene transcription profiles of immune responses elicited by HIV lipopeptide vaccine in HIV-negative volunteers
    • Richert L, Hue S, Hocini H et al. Cytokine and gene transcription profiles of immune responses elicited by HIV lipopeptide vaccine in HIV-negative volunteers. AIDS 27(9), 1421-1431 (2013).
    • (2013) AIDS , vol.27 , Issue.9 , pp. 1421-1431
    • Richert, L.1    Hue, S.2    Hocini, H.3
  • 172
    • 0032535760 scopus 로고    scopus 로고
    • The importance of local mucosal HIV-specific CD8(+) cytotoxic T lymphocytes for resistance to mucosal viral transmission in mice and enhancement of resistance by local administration of IL-12
    • Belyakov IM, Ahlers JD, Brandwein BY et al. The importance of local mucosal HIV-specific CD8(+) cytotoxic T lymphocytes for resistance to mucosal viral transmission in mice and enhancement of resistance by local administration of IL-12. J. Clin. Invest. 102(12), 2072-2081 (1998).
    • (1998) J. Clin. Invest , vol.102 , Issue.12 , pp. 2072-2081
    • Belyakov, I.M.1    Ahlers, J.D.2    Brandwein, B.Y.3
  • 173
    • 0031660670 scopus 로고    scopus 로고
    • Induction of a mucosal cytotoxic T-lymphocyte response by intrarectal immunization with a replication-deficient recombinant vaccinia virus expressing human immunodeficiency virus 89.6 envelope protein
    • Belyakov IM, Wyatt LS, Ahlers JD et al. Induction of a mucosal cytotoxic T-lymphocyte response by intrarectal immunization with a replication-deficient recombinant vaccinia virus expressing human immunodeficiency virus 89.6 envelope protein. J. Virol. 72(10), 8264-8272 (1998).
    • (1998) J. Virol , vol.72 , Issue.10 , pp. 8264-8272
    • Belyakov, I.M.1    Wyatt, L.S.2    Ahlers, J.D.3
  • 174
    • 70350532251 scopus 로고    scopus 로고
    • Strategies for optimizing targeting and delivery of mucosal HIV vaccines
    • Ahlers JD, Belyakov IM. Strategies for optimizing targeting and delivery of mucosal HIV vaccines. Eur. J. Immunol. 39(10), 2657-2669 (2009).
    • (2009) Eur. J. Immunol , vol.39 , Issue.10 , pp. 2657-2669
    • Ahlers, J.D.1    Belyakov, I.M.2
  • 175
    • 11144355994 scopus 로고    scopus 로고
    • Comparative analysis using a mouse model of the immunogenicity of artificial VLP and attenuated Salmonella strain carrying a DNA-vaccine encoding HIV-1 polyepitope CTL-immunogen
    • Karpenko LI, Nekrasova NA, Ilyichev AA et al. Comparative analysis using a mouse model of the immunogenicity of artificial VLP and attenuated Salmonella strain carrying a DNA-vaccine encoding HIV-1 polyepitope CTL-immunogen. Vaccine 22(13-14), 1692-1699 (2004).
    • (2004) Vaccine , vol.22 , Issue.13-14 , pp. 1692-1699
    • Karpenko, L.I.1    Nekrasova, N.A.2    Ilyichev, A.A.3
  • 176
    • 53849088921 scopus 로고    scopus 로고
    • Generation of functionally active HIV-1 specific CD8(+) CTL in intestinal mucosa following mucosal, systemic or mixed prime-boost immunization
    • Belyakov IM, Ahlers JD, Nabel GJ, Moss B, Berzofsky JA. Generation of functionally active HIV-1 specific CD8(+) CTL in intestinal mucosa following mucosal, systemic or mixed prime-boost immunization. Virology 381(1), 106-115 (2008).
    • (2008) Virology , vol.381 , Issue.1 , pp. 106-115
    • Belyakov, I.M.1    Ahlers, J.D.2    Nabel, G.J.3    Moss, B.4    Berzofsky, J.A.5
  • 177
    • 84864338756 scopus 로고    scopus 로고
    • Recent progress in mucosal vaccine development: Potential and limitations
    • Lycke N. Recent progress in mucosal vaccine development: potential and limitations. Nat. Rev. Immunol. 12(8), 592-605 (2012).
    • (2012) Nat. Rev. Immunol , vol.12 , Issue.8 , pp. 592-605
    • Lycke, N.1
  • 178
    • 82255164138 scopus 로고    scopus 로고
    • Towards a systems understanding of MHC class i and MHC class II antigen presentation
    • Neefjes J, Jongsma MLM, Paul P, Bakke O. Towards a systems understanding of MHC class I and MHC class II antigen presentation. Nat. Rev. Immunol. 11(12), 823-836 (2011).
    • (2011) Nat. Rev. Immunol , vol.11 , Issue.12 , pp. 823-836
    • Neefjes, J.1    Mlm, J.2    Paul, P.3    Bakke, O.4
  • 180
    • 33947505235 scopus 로고    scopus 로고
    • A hybrid approach for predicting promiscuous MHC class i restricted T cell epitopes
    • Bhasin M, Raghava GPS. A hybrid approach for predicting promiscuous MHC class I restricted T cell epitopes. J. Biosci. 32(1), 31-42 (2007).
    • (2007) J. Biosci , vol.32 , Issue.1 , pp. 31-42
    • Bhasin, M.1    Raghava, G.P.S.2
  • 182
    • 7944235990 scopus 로고    scopus 로고
    • A structure-based approach for prediction of MHC-binding peptides
    • Altuvia Y, Margalit H. A structure-based approach for prediction of MHC-binding peptides. Methods 34(4), 454-459 (2004).
    • (2004) Methods , vol.34 , Issue.4 , pp. 454-459
    • Altuvia, Y.1    Margalit, H.2
  • 183
    • 71949096416 scopus 로고    scopus 로고
    • Derivation of an amino acid similarity matrix for peptide: MHC binding and its application as a Bayesian prior
    • Kim Y, Sidney J, Pinilla C, Sette A, Peters B. Derivation of an amino acid similarity matrix for peptide: MHC binding and its application as a Bayesian prior. BMC Bioinformatics 10(2009).
    • (2009) BMC Bioinformatics , vol.10
    • Kim, Y.1    Sidney, J.2    Pinilla, C.3    Sette, A.4    Peters, B.5
  • 184
    • 21344466799 scopus 로고    scopus 로고
    • Automated generation and evaluation of specific MHC binding predictive tools: ARB matrix applications
    • Bui HH, Sidney J, Peters B et al. Automated generation and evaluation of specific MHC binding predictive tools: ARB matrix applications. Immunogenetics 57(5), 304-314 (2005).
    • (2005) Immunogenetics , vol.57 , Issue.5 , pp. 304-314
    • Bui, H.H.1    Sidney, J.2    Peters, B.3
  • 186
    • 38849139819 scopus 로고    scopus 로고
    • Efficient peptideMHC-I binding prediction for alleles with few known binders
    • Jacob L, Vert JP. Efficient peptideMHC-I binding prediction for alleles with few known binders. Bioinformatics 24(3), 358-366 (2008).
    • (2008) Bioinformatics , vol.24 , Issue.3 , pp. 358-366
    • Jacob, L.1    Vert, J.P.2
  • 187
    • 48449106045 scopus 로고    scopus 로고
    • NetMHC-3.0: Accurate web accessible predictions of human, mouse and monkey MHC class i affinities for peptides of length 8-11
    • Lundegaard C, Lamberth K, Harndahl M, Buus S, Lund O, Nielsen M. NetMHC-3.0: accurate web accessible predictions of human, mouse and monkey MHC class I affinities for peptides of length 8-11. Nucleic Acids Res. 36, W509-W512 (2008).
    • (2008) Nucleic Acids Res , vol.36
    • Lundegaard, C.1    Lamberth, K.2    Harndahl, M.3    Buus, S.4    Lund, O.5    Nielsen, M.6
  • 188
    • 39549084433 scopus 로고    scopus 로고
    • NetMHCpan, a method for quantitative predictions of peptide binding to any HLA-A and -B locus protein of known sequence
    • Nielsen M, Lundegaard C, Blicher T et al. NetMHCpan, a method for quantitative predictions of peptide binding to any HLA-A and -B locus protein of known sequence. PLoS ONE 2(8) (2007).
    • (2007) PLoS ONE , vol.2 , Issue.8
    • Nielsen, M.1    Lundegaard, C.2    Blicher, T.3
  • 189
    • 44649167715 scopus 로고    scopus 로고
    • Application of machine learning techniques in predicting MHC binders
    • Lata S, Bhasin M, Raghava GP. Application of machine learning techniques in predicting MHC binders. Methods Mol. Biol. 409, 201-215 (2007).
    • (2007) Methods Mol. Biol , vol.409 , pp. 201-215
    • Lata, S.1    Bhasin, M.2    Raghava, G.P.3
  • 190
    • 77956922389 scopus 로고    scopus 로고
    • MultiRTA: A simple yet reliable method for predicting peptide binding affinities for multiple class II MHC allotypes
    • Bordner AJ, Mittelmann HD. MultiRTA: a simple yet reliable method for predicting peptide binding affinities for multiple class II MHC allotypes. BMC Bioinformatics 11 (2010).
    • (2010) BMC Bioinformatics , vol.11
    • Bordner, A.J.1    Mittelmann, H.D.2
  • 191
    • 84893061221 scopus 로고    scopus 로고
    • ClinicalTrials.gov
    • ClinicalTrials.gov (2013). http://clinicaltrials.gov/
    • (2013)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.